Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUROSMART: Symbicort SMART maintenance dose comparison in persistent asthma
2006-006512-30Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide in persistent asthma and asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Time to first severe asthma exacerbation. Started Dec 2006; status: completed.
02
Drugs
budesonide
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2006-006512-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006512-30.